Diabetic nephropathy: What does the future hold?
The consensus management of diabetic nephropathy (DN) in 2015 involves good control of glycaemia, dyslipidaemia and blood pressure (BP). Blockade of the renin–angiotensin–aldosterone system using angiotensin-converting enzyme inhibitors, angiotensin-2 receptor blockers or mineralocorticoid inhibito...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer Netherlands
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705119/ |